Hyperleukocytosis in Cancer Patients
Gowda L, Hosing C. Hyperleukocytosis in Cancer Patients. 2019, 1147-1153. DOI: 10.1007/978-3-319-74588-6_94.Peer-Reviewed Original ResearchTumor lysis syndromeWhite blood cellsDefinitive therapyPeripheral blood white blood cellsBlood white blood cellsSupportive care measuresHigh WBC countSymptomatic hyperleukocytosisLysis syndromeCoagulation abnormalitiesIntravascular coagulationLethal complicationAvoidable complicationsPoor prognosisCancer patientsWBC countCare measuresSymptomatic courseMalignant cloneHyperleukocytosisAggressive natureTherapeutic interventionsBiologic driversComplicationsBlood cellsHyperleukocytosis in Cancer Patients
Gowda L, Hosing C. Hyperleukocytosis in Cancer Patients. 2019, 1-7. DOI: 10.1007/978-3-319-74698-2_94-1.Peer-Reviewed Original ResearchTumor lysis syndromeWhite blood cellsDefinitive therapyPeripheral blood white blood cellsBlood white blood cellsSupportive care measuresHigh WBC countSymptomatic hyperleukocytosisLysis syndromeCoagulation abnormalitiesIntravascular coagulationLethal complicationAvoidable complicationsPoor prognosisCancer patientsWBC countCare measuresSymptomatic courseMalignant cloneHyperleukocytosisAggressive natureTherapeutic interventionsBiologic driversComplicationsBlood cellsAllogeneic stem cell transplantation and combination antiretroviral therapy: cautions, complications, and considerations
Shallis RM, Gleeson S, Azar M, Malinis M, Xu ML, Seropian SE, Gowda L, Zeidan AM. Allogeneic stem cell transplantation and combination antiretroviral therapy: cautions, complications, and considerations. Leukemia & Lymphoma 2019, 60: 2584-2587. PMID: 30943051, DOI: 10.1080/10428194.2019.1594221.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements